Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Sep 14:10:492.
doi: 10.1186/1471-2407-10-492.

Determining the role of external beam radiotherapy in unresectable intrahepatic cholangiocarcinoma: a retrospective analysis of 84 patients

Yi-Xing Chen  1 , Zhao-Chong Zeng, Zhao-You Tang, Jia Fan, Jian Zhou, Wei Jiang, Meng-Su Zeng, Yun-Shan Tan
Affiliations

Determining the role of external beam radiotherapy in unresectable intrahepatic cholangiocarcinoma: a retrospective analysis of 84 patients

Yi-Xing Chen et al. BMC Cancer. .

Abstract

Background: Intrahepatic cholangiocarcinoma (ICC) is the second most common type of primary liver cancer. Only few studies have focused on palliative radiotherapy used for patients who weren't suitable for resection by surgery. This study was conducted to investigate the effect of external beam radiotherapy (EBRT) for patients with unresectable ICC.

Methods: We identified 84 patients with ICC from December 1998 through December 2008 for retrospective analysis. Thirty-five of 84 patients received EBRT therapy five times a week (median dose, 50 Gy; dose range, 30-60 Gy, in fractions of 1.8-2.0 Gy daily; EBRT group); the remaining 49 patients comprised the non-EBRT group. Tumor response, jaundice relief, and survival rates were compared by Kaplan-Meier analysis. Patient records were reviewed and compared using Cox proportional hazard analysis to determine factors that affect survival time in ICC.

Results: After EBRT, complete response (CR) and partial response (PR) of primary tumors were observed in 8.6% and 28.5% of patients, respectively, and CR and PR of lymph node metastases were observed in 20% and 40% of patients. In 19 patients with jaundice, complete and partial relief was observed in 36.8% and 31.6% of patients, respectively. Median survival times were 5.1 months for the non-EBRT group and 9.5 months for the EBRT group (P = 0.003). One-and two-year survival rates for EBRT versus non-EBRT group were 38.5% versus 16.4%, and 9.6% versus 4.9%, respectively. Multivariate analysis revealed that clinical symptoms, larger tumor size, no EBRT, multiple nodules and synchronous lymph node metastases were associated with poorer prognosis.

Conclusions: EBRT as palliative care appears to improve prognosis and relieve the symptom of jaundice in patients with unresectable ICC.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Three-dimensional conformal radiation therapy for intrahepatic cholangiocarcinoma (ICC) patient with asynchronous hepatic portal, peri-pancreas, and para-aorta lymph node metastases, showing delineation of plan tumor target volume 1 (PTV1) and plan target volume 2 (PTV2) for 50.4 Gy/28 Fx and 41.4 Gy/23 Fx, dose distribution, and dose volume histogram (DVH) for tumor targets and organs at risk.
Figure 2
Figure 2
Overall survival curves for EBRT and non-EBRT groups.
See this image and copyright information in PMC

References

    1. Shaib YH, Davila JA, McGlynn K. et al.Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase? J Hepatol. 2004;40:472–477. doi: 10.1016/j.jhep.2003.11.030. - DOI - PubMed
    1. Ikai I, Itai YJ, Okita K. et al.Report of the 15th follow-up surgery of primary liver cancer. Hepatology Res. 2004;28:21–29. doi: 10.1016/j.hepres.2003.08.002. - DOI - PubMed
    1. Weber SM, Jarnagin WR, Klimstra D. et al.Intrahepatic cholangiocarcinoma: resectability, recurrence pattern, and outcomes. J Am Coll Surg. 2001;193:384–391. doi: 10.1016/S1072-7515(01)01016-X. - DOI - PubMed
    1. Saxena A, Chua TC, Sarkar A. et al.Clinicopathologic and treatment-related factors influencing recurrence and survival after hepatic resection of intrahepatic cholangiocarcinoma: a 19-year experience from an established Australian hepatobiliary unit. J Gastrointest Surg. 2010;14(7):1128–38. doi: 10.1007/s11605-010-1203-1. - DOI - PubMed
    1. Lang H, Sotiropoulos GC, Sgourakis G. et al.Operations for intrahepatic cholangiocarcinoma: single-institution experience of 158 patients. J Am Coll Surg. 2009;208(2):218–28. doi: 10.1016/j.jamcollsurg.2008.10.017. - DOI - PubMed

MeSH terms